• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
Clarius PAL HD3 wireless scanner

Clarius Mobile Health Named to Fast Company's 2024 List

Clarius Mobile Health, a global leader in wireless ultrasound solutions, has been named to Fast Company's prestigious annual list of the World's Most Innovative Companies. Clarius earned the #2 standing in the medical device category for its outstanding contributions to improving healthcare with innovation.

Read more →
Tyber Medical Anatomical Plating System

Tyber Medical Anatomical Plating System Cleared For Canada

Tyber Medical LLC, a leading orthopedic device manufacturer providing private label orthopedic implants for the trauma, extremity, and spine markets, received clearance for the anatomical plating system in Canada. The comprehensive portfolio previously received FDA 510(k) in the US and has now been cleared through Health Canada.

Read more →
PCI's BlueCrest Vantage

PCI® boosts capacity with high-tech BlueCrest mail sorters

In keeping with its mission to embrace innovation and leverage cutting-edge technology, Postal Center International® (PCI®) has made a strategic investment in not one but two new state-of-the-art BlueCrest Vantage Mixed Thickness and Mixed Weight Flat Sorters — the first ones in the United States running on the NetSort platform.

Read more →
Bear Robotics

Transforming Healthcare: Sodexo and Bear Robotics Revolutionize Patient Support

In a landmark collaboration, Sodexo, a global leader in quality-of-life services, is expanding its partnership with Bear Robotics, the Silicon Valley innovator behind indoor self-driving service robots. Together, they are reshaping healthcare services, ushering in a new era of patient and staff support and care that will establish an industry benchmark for excellence.

Read more →
Immunotherapies

GE HealthCare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies

GE HealthCare’s Artificial Intelligence (AI) models predict patient response to immunotherapies with 70 to 80 percent accuracy1, based on a pan-cancer cohort, according to findings to be presented at the Society for Immunotherapy of Cancer (SITC) in San Diego, U.S., by GE HealthCare, Vanderbilt University Medical Center (VUMC) and the University Medicine Essen (UME), Germany.

Read more →